We came across a bullish thesis on Novo Nordisk A/S on r/Valueinvesting by Quorum_Ataraxia. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S's share was trading at $59.43 as of January 30th. NVO’s trailing and forward P/E were 15.80 and 16.18 respectively according to Yahoo Finance.
[caption id="attachment_1197755" align="aligncenter" width="768"]Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.